Research graph
References from Infiltrative Cardiomyopathies. Local targets link to admitted publications; unresolved targets remain external evidence.
CMR-Based differentiation of AL and ATTR cardiac amyloidosis
10.1016/j.jcmg.2013.08.015 · 2014 · External reference
Multi-imaging characterization of cardiac phenotype in different types of amyloidosis
10.1016/j.jcmg.2022.07.008 · 2023 · External reference
Rare forms of cardiac amyloidosis: diagnostic clues and phenotype in apo AI and AIV amyloidosis
10.1161/circimaging.123.015259 · 2023 · External reference
Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis
10.1001/jamacardio.2024.2555 · 2024 · External reference
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
10.1093/eurheartj/ehac363 · 2022 · External reference
Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping
10.1001/jamacardio.2023.2010 · 2023 · External reference
Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis
10.1001/jamacardio.2022.2981 · 2022 · External reference
Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta‐analysis of gross pathological images from autopsy or cardiac transplantation cases
10.1161/jaha.118.011253 · 2019 · External reference
Late gadolinium enhancement on cardiac magnetic resonance in suspected cardiac sarcoidosis
10.1016/j.jcmg.2022.11.022 · 2023 · External reference
Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement
10.1093/eurheartj/ehaf338 · 2025 · External reference
Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis
10.1001/jamacardio.2022.2981 · ExternalCitation · doi-reference
Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping
10.1001/jamacardio.2023.2010 · ExternalCitation · doi-reference
Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis
10.1001/jamacardio.2024.2555 · ExternalCitation · doi-reference
CMR-Based differentiation of AL and ATTR cardiac amyloidosis
10.1016/j.jcmg.2013.08.015 · ExternalCitation · doi-reference
Multi-imaging characterization of cardiac phenotype in different types of amyloidosis
10.1016/j.jcmg.2022.07.008 · ExternalCitation · doi-reference
Late gadolinium enhancement on cardiac magnetic resonance in suspected cardiac sarcoidosis
10.1016/j.jcmg.2022.11.022 · ExternalCitation · doi-reference
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
10.1093/eurheartj/ehac363 · ExternalCitation · doi-reference
Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement
10.1093/eurheartj/ehaf338 · ExternalCitation · doi-reference
Rare forms of cardiac amyloidosis: diagnostic clues and phenotype in apo AI and AIV amyloidosis
10.1161/circimaging.123.015259 · ExternalCitation · doi-reference
Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta‐analysis of gross pathological images from autopsy or cardiac transplantation cases
10.1161/jaha.118.011253 · ExternalCitation · doi-reference
